Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
35
ACAD Quote, Financials, Valuation and Earnings
Last price:
$14.56
Seasonality move
:
7.61%
Day range:
$13.73 - $14.61
52-week range:
$13.40 - $20.68
Dividend yield:
0%
P/E ratio:
10.72x
P/S ratio:
2.53x
P/B ratio:
3.32x
Volume:
1.9M
Avg. volume:
1.8M
1-year change:
-16.26%
Market cap:
$2.4B
Revenue:
$957.8M
EPS (TTM):
$1.36
ACAD Analysts' Consensus Rating
The 13 analysts providing 12-month price projections for ACADIA Pharmaceuticals shares anticipate an average target of $25.11, ranging from a low estimate of $11.00 to a high estimate of $37.00. This average target implies a growth of 72.19% compared to the current stock price of $14.58.
Consensus Price Target
$25.11
Highest Price Target
$37.00
Lowest Price Target
$11.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 7 | 6 | 6 |
| Hold | 6 | 7 | 7 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Hold | Hold |
ACAD Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
